Literature DB >> 21284579

Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus.

Dilip Shah1, Ashish Aggarwal, Archana Bhatnagar, Ravi Kiran, Ajay Wanchu.   

Abstract

Increased oxidative stress and lymphocyte apoptosis are a hallmark of the autoimmune disease systemic lupus erythematosus (SLE). However, the association between oxidative stress and T lymphocytes apoptosis has still to be elucidated in SLE. In order to appraise the interaction between oxidative stress and T lymphocyte apoptosis with the severity of disease, oxidative stress profile and T lymphocytes apoptosis were studied. Increased levels of ROS, MDA and CD4(+) lymphocyte apoptosis were positively associated with disease activity while decreased levels of GSH and percentage expression of CD4(+) lymphocyte were negatively associated with disease activity. The decrease in intracellular levels of GSH was negatively associated with T lymphocyte, CD4(+) lymphocyte, CD8(+) lymphocyte apoptosis and intracellular caspase-3 expression. The present study suggests that increased T lymphocyte sub-sets apoptosis may be mediated by decreased intracellular glutathione concentration and severity of disease might be enhanced together by over-production of ROS in SLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21284579     DOI: 10.3109/10715762.2011.555765

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  26 in total

1.  Lupus at the molecular level.

Authors:  Mayami Sengupta; Laurence Morel
Journal:  Protein Cell       Date:  2011-12       Impact factor: 14.870

2.  Lymphopenia relating to T-lymphocyte apoptosis in systemic lupus erythematosus.

Authors:  Weiqian Chen; Jin Lin
Journal:  Clin Rheumatol       Date:  2011-09-17       Impact factor: 2.980

Review 3.  Interaction between glutathione and apoptosis in systemic lupus erythematosus.

Authors:  Dilip Shah; Sangita Sah; Swapan K Nath
Journal:  Autoimmun Rev       Date:  2012-12-29       Impact factor: 9.754

Review 4.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

5.  Altered glutamate cysteine ligase expression and activity in renal cell carcinoma.

Authors:  Monong Li; Zongliang Zhang; Jiangshui Yuan; Yanlun Zhang; Xunbo Jin
Journal:  Biomed Rep       Date:  2014-09-09

6.  Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis.

Authors:  Ashish Aggarwal; Aman Sharma; Archana Bhatnagar
Journal:  Clin Rheumatol       Date:  2014-05-07       Impact factor: 2.980

Review 7.  Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus.

Authors:  Carol M Greco; Claire Nakajima; Susan Manzi
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

Review 8.  Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus.

Authors:  Xiangyu Teng; Josephine Brown; Laurence Morel
Journal:  Antioxid Redox Signal       Date:  2022-01-04       Impact factor: 8.401

9.  N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.

Authors:  Zhi-Wei Lai; Robert Hanczko; Eduardo Bonilla; Tiffany N Caza; Brandon Clair; Adam Bartos; Gabriella Miklossy; John Jimah; Edward Doherty; Hajra Tily; Lisa Francis; Ricardo Garcia; Maha Dawood; Jianghong Yu; Irene Ramos; Ioana Coman; Stephen V Faraone; Paul E Phillips; Andras Perl
Journal:  Arthritis Rheum       Date:  2012-09

Review 10.  Oxidative stress in the pathology and treatment of systemic lupus erythematosus.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2013-10-08       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.